title: Immunological effects of recombinant human erythropoietin on end-stage renal disease pediatric and adult patients.
authors.forename: F
authors.initials: F
authors.lastname: Salvati
authors.forename: M
authors.initials: M
authors.lastname: Liani
authors.forename: M
authors.initials: M
authors.lastname: La Torre
authors.forename: M
authors.initials: M
authors.lastname: Golato
authors.forename: N
authors.initials: N
authors.lastname: Di Sciascio
authors.forename: J
authors.initials: J
authors.lastname: Pietrzyk
authors.forename: P
authors.initials: P
authors.lastname: Dyras
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D004921:Erythropoietin